Detalles de la búsqueda
1.
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
Blood Adv
; 8(8): 1835-1845, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386975
2.
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.
Leuk Lymphoma
; : 1-11, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710017
3.
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.
Transplantation
; 107(12): 2561-2567, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389645
4.
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.
Virchows Arch
; 2023 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37851120
5.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Cancers (Basel)
; 15(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686611
Resultados
1 -
5
de 5
1
Próxima >
>>